Health Economic Analysis
Medip Analytics offers a Health Economic Analysis service for your diagnostic, prognostic, or companion diagnostic products across all disease areas. Our expert team leverages our proprietary Health Economic Software to conduct in-depth assessments that reveal your product's true market potential.
Through our systematic approach, we develop three strategic scenarios that show your product's value proposition from every angle. Each analysis provides:
- Cost-effectiveness metrics that matter to decision-makers
- Market access opportunities and potential barriers
- Value-based pricing recommendations
Armed with these powerful insights, you can confidently position your product in the market, engage with payers, and maximize your return on investment.
Over 13 years of experience in health technology assessment, software development and data-analytics
All the right tools for the dynamic assessment of the value of a technology
Our Experiences
Medip Analytics has a wide experience over technologies and disease areas.
>7
Technologies
- Liquid biopsies
- (Epi)genetic markers
- Imaging techniques
- Image-guided therapies
- AI Algorithms
- Devices
- Implants
- and more..
>18
Disease areas
- Airway infections
- Bladder cancer
- Breast cancer
- Cardiac arrhythmias
- Colorectal cancers
- COPD
- Dementia
- Endometrial cancer
- Endometriosis
- Head and neck cancer
- Leukemia
- Lung cancer
- Melanoma
- Meniscus injuries
- Prostate cancer
- Schwannoma
- Stroke detection
- Ulcerative colitis
- and more..
